Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance
Theresa A. Boyle(Moffitt Cancer Center), Fred R. Hirsch(Tisch Hospital), Gabriel Sica(Emory University), Marileila Varella‐Garcia(University of Colorado Anschutz Medical Campus), Lynne D. Berry(Vanderbilt University Medical Center), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), André L. Moreira(NYU Langone Health), Mark G. Kris(Memorial Sloan Kettering Cancer Center), James J. Saller(Moffitt Cancer Center), Farah Khalil(University of South Florida), Christopher J. Rivard(University of Colorado Denver), Eric B. Haura(Moffitt Cancer Center), Paul A. Bunn(University of Colorado Denver), Mari Mino–Kenudson(Massachusetts General Hospital), Mirna Z. Knight(University Pathologists), Junya Fujimoto(The University of Texas MD Anderson Cancer Center), Lynette M. Sholl(Brigham and Women's Hospital), David J. Kwiatkowski(Brigham and Women's Hospital), Kim E. Ellison, Kelly Kugler(Michigan Cancer Research Consortium), Heidi Chen(Vanderbilt University Medical Center)
Cited by 11
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Lung cancer: current therapies and new targeted treatments
|The Lancet|2016|3.3k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k